MS Freedman

Differential diagnosis of suspected multiple sclerosis: a consensus approach

DH Miller, BG Weinshenker, Massimo Filippi et al. · Multiple Sclerosis Journal · 2008 · 641 citations · Full text

Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosis

Timothy R. Vollmer, Hillel Panitch, Amit Bar‐Or et al. · Multiple Sclerosis Journal · 2008 · 94 citations

Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with ‘aggressive’ multiple sclerosis

Joyutpal Das, Joachim Burman, MS Freedman et al. · Multiple Sclerosis Journal · 2021 · 41 citations · Full text

Cell Therapy, Immunology, Transplantation Medicine +16

Shorter infusion time of ocrelizumab: Results from the randomized, double-blind ENSEMBLE PLUS substudy in patients with relapsing-remitting multiple sclerosis

H-P Hartung, Thomas Berger, R. Bermel et al. · Multiple Sclerosis and Related Disorders · 2020 · 26 citations · Full text

Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysis

MS Freedman, Carola Metzig, Ludwig Kappos et al. · Multiple Sclerosis Journal · 2011 · 13 citations · Full text